Boehringer Ingelheim claims indolinone kinase inhibitors with antiproliferative activity April 19, 2001
Antitumor agent with excellent oral activity revealed by Daiichi at recent Japanese meeting April 19, 2001
Antiangiogenic and antitumor effects demonstrated in mice for new VEGF RTK inhibitor AG-13925 April 19, 2001
DAB-1059, an inhibitor of EGF receptor tyrosine kinase with nanomolar potency and antitumor activity April 19, 2001
Korean research suggests potential in HPV-associated cervical cancer for new arsenic compound April 18, 2001
RSS